News on Appendix from BioPortfolio.com http://www.BioPortfolio.com Consolidated Appendix news from BioPortfolio.com Wed, 10 Feb 2010 16:02:45 GMT en Sanofi-aventis Delivers Double-Digit EPS Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042559&HITNO=0&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042559&THISHREF=http://c.moreover.com/click/here.pl%3fz2539454271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042559&HITNO=0&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042559&THISHREF=http://c.moreover.com/click/here.pl%3fz2539454271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042027&HITNO=1&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042027&THISHREF=http://c.moreover.com/click/here.pl%3fz2539281807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042027&HITNO=1&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042027&THISHREF=http://c.moreover.com/click/here.pl%3fz2539281807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041776&HITNO=2&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041776&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041776&HITNO=2&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041776&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041722&HITNO=3&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041722&THISHREF=http://c.moreover.com/click/here.pl%3fz2539213298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041722&HITNO=3&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041722&THISHREF=http://c.moreover.com/click/here.pl%3fz2539213298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041688&HITNO=4&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041688&THISHREF=http://c.moreover.com/click/here.pl%3fz2539205438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041688&HITNO=4&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041688&THISHREF=http://c.moreover.com/click/here.pl%3fz2539205438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041610&HITNO=5&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041610&THISHREF=http://c.moreover.com/click/here.pl%3fz2539180953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041610&HITNO=5&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041610&THISHREF=http://c.moreover.com/click/here.pl%3fz2539180953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041577&HITNO=6&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041577&THISHREF=http://c.moreover.com/click/here.pl%3fz2539173652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041577&HITNO=6&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041577&THISHREF=http://c.moreover.com/click/here.pl%3fz2539173652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041553&HITNO=7&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041553&THISHREF=http://c.moreover.com/click/here.pl%3fz2539163941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041553&HITNO=7&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041553&THISHREF=http://c.moreover.com/click/here.pl%3fz2539163941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041530&HITNO=8&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041530&THISHREF=http://c.moreover.com/click/here.pl%3fz2539159192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041530&HITNO=8&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041530&THISHREF=http://c.moreover.com/click/here.pl%3fz2539159192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041528&HITNO=9&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041528&THISHREF=http://c.moreover.com/click/here.pl%3fz2539159006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041528&HITNO=9&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041528&THISHREF=http://c.moreover.com/click/here.pl%3fz2539159006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSys-Con Media: Cancer Institute aims to offer patients latest treatmentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041049&HITNO=10&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041049&THISHREF=http://c.moreover.com/click/here.pl%3fz2538986512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041049&HITNO=10&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041049&THISHREF=http://c.moreover.com/click/here.pl%3fz2538986512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDaytona Beach News Journal: Reform Pharma plc : Withdrawal From PLUS Marketshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036139&HITNO=11&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036139&THISHREF=http://c.moreover.com/click/here.pl%3fz2536506552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036139&HITNO=11&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036139&THISHREF=http://c.moreover.com/click/here.pl%3fz2536506552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInvestegate: Research and Markets: Top Life Sciences Information Technology Outsourcing Vendors, Black Book Survey 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035663&HITNO=12&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035663&THISHREF=http://c.moreover.com/click/here.pl%3fz2536321632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035663&HITNO=12&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035663&THISHREF=http://c.moreover.com/click/here.pl%3fz2536321632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: MedaSorb's (MSBT.OB) Answer to Unmet Medical Need Could Be Commercialized This Yearhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029660&HITNO=13&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029660&THISHREF=http://c.moreover.com/click/here.pl%3fz2533224085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029660&HITNO=13&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029660&THISHREF=http://c.moreover.com/click/here.pl%3fz2533224085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: MedaSorb's (MSBT.OB) Answer to Unmet Medical Need Could Be Commercialized This Yearhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029646&HITNO=14&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029646&THISHREF=http://c.moreover.com/click/here.pl%3fz2533219321%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029646&HITNO=14&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Appendix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029646&THISHREF=http://c.moreover.com/click/here.pl%3fz2533219321%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: